Abstract: A device for producing a subwavelength hologram. The device comprises a metasurface layer attached to a substrate. The metasurface layer includes an array of plasmonic antennas that simultaneously encode both wavelength and phase information of light directed through the array to produce a hologram. The wavelength is determined by the size of the antennas, and the phase is determined by the orientation of the antennas.

Abstract: Systems and methods suitable for capable of autonomous crack detection in surfaces by analyzing video of the surface. The systems and methods include the capability to produce a video of the surfaces, the capability to analyze individual frames of the video to obtain surface texture feature data for areas of the surfaces depicted in each of the individual frames, the capability to analyze the surface texture feature data to detect surface texture features in the areas of the surfaces depicted in each of the individual frames, the capability of tracking the motion of the detected surface texture features in the individual frames to produce tracking data, and the capability of using the tracking data to filter non-crack surface texture features from the detected surface texture features in the individual frames.

Abstract: Provided is a non-motorized flying unit. The non-motorized flying unit includes a body part having a head part and a tail part having an accommodation space and a through hole, an image capturing unit installed in the through hole and configured to obtain an image information, a protective window installed in the through hole, a plurality of shock absorbing devices installed at the end portion of the tail part, a weight installed at the end portion of the tail part, and a lighting device installed at an end portion of the plurality of shock absorbing devices. A propulsion unit which is detachably coupled to the tail part storing a propellant which, upon combustion, forms pressure in the propulsion unit to provide thrust to the body part.

Abstract: The present disclosure provides novel poly(phenylene ethynylene) (PPE) compounds, methods for synthesizing these compounds, and materials and substances incorporating these compounds. The various PPEs show antibacterial, antiviral and antifungal activity.

Abstract: In one aspect, the invention relates to a method for identifying a compound which modulates the activity of a voltage-gated protein. In certain embodiments, the voltage gate protein is a voltage-gated ion channel. In certain embodiments, the voltage-gated protein is a voltage sensitive phosphatase. In certain embodiments, the voltage-gated protein used in conjunction with the methods of the invention is modified to altered permeability or voltage sensitivity.

Abstract: General Formula (I) Provided is an all solid state secondary-battery additive comprising a polyalkylene carbonate (I) represented by general formula (I), and by providing such additive, properties such as the charge-discharge capacity and interfacial resistance of an all-solid-state secondary battery are improved. (In general formula (I), R1 and R2 are each a C1-10 chain-like alkylene group or C3-10 cycloalkylene group, m is 0, 1, or 2 and n is an integer of 10 to 15000, and each R1, R2 and m in the polyalkylene carbonate (I) chain is independently the same or different.

Abstract: A non-transitory computer-readable medium encoded with a computer-readable program which, when executed by a first processor, will cause a computer to execute a method of authenticating a user, the method including training a plurality of models. The method additionally includes sending, by a computer, an acoustic signal. Further, the method includes receiving, by the computer, a reflected acoustic signal, wherein the reflected acoustic signal comprises information about a signature. Moreover, the method includes receiving, by the computer, motion data about the information about the signature. The method additionally includes comparing the information about the signature to a model to generate a score. Additionally, the method includes deciding, based on the score, if the information about the signature is within a predetermined tolerance level.

Abstract: This disclosure provides pharmaceutical compositions and purified or isolated naturally occurring exosome products that have therapeutic use for treating an unmet medical need. The exosome compositions contain an effective amount of exosomes isolated from a body fluid of a non-diseased subject. The compositions are useful in the treatment of a variety of fibrotic diseases.

Abstract: A modified boron nitride nanotube (BNNT) comprising pendant hydroxyl (OH) and amino (NH2) functional groups covalently bonded to a surface of the BNNT. Aqueous and organic solutions of these modified BNNTs are disclosed, along with methods of producing the same. The modified BNNTs and their solutions can be used to coat substrates and to make nanocomposites.

Abstract: To provide an optical element that can be more easily aligned with an optical fiber, an optical element includes one grating coupler optically coupled to an optical fiber, a waveguide connected to the grating coupler, a multimode interferometer connected to the waveguide on the opposite side to the grating coupler, and a waveguide inserted between two input/output ports on the branched side of the multimode interferometer.

Abstract: Provided is a method for manufacturing a semiconductor package, the method including providing a semiconductor chip on a substrate, providing a bonding member between the substrate and the semiconductor chip, and bonding the semiconductor chip on the substrate by irradiating of a laser on the substrate. Here, the bonding member may include a thermosetting resin, a curing agent, and a laser absorbing agent.

Abstract: Methods and kits for diagnosing systemic lupus erythematosus (SLE) in a subject are provided. Particularly, the present invention relates to specific oligonucleotide antibody reactivities useful in diagnosing SLE in a subject.

Abstract: Provided is a method of inhibiting protein kinase C zeta/protein kinase M zeta, including contacting a sample containing an isoform of protein kinase C zeta with a compound of formula: referred to as 1-naphthol-3,6,8-trisulphonic acid, or a pharmaceutically acceptable salt thereof. In some embodiments, contacting the sample with the compound does not inhibit protein kinase C iota/lambda. In a specific example, the sample includes neural tissue, the isoform of protein kinase C zeta is protein kinase M zeta, and inhibiting includes reducing kinase activity and further includes diminishing long-term potentiation. In some embodiment, the method includes inhibiting glucose transport. Also provided is a method of affecting memory, including administering the compounds to a mammalian organism.

Abstract: A method for separating and recycling a waste polyester-cotton textile by a hydrothermal reaction catalyzed by an organic acid, comprising the following steps: dividing a waste polyester-cotton textile into fragments and dispersing in an aqueous solution system of the organic acid catalyst to obtain a mixed system; in a high-pressure reactor, heating the mixed system to 110˜180° C. so that cotton fibers in the waste polyester-cotton textile undergo a degradation reaction for 0.5˜3 h to obtain a mixture; and filtering the mixture by a sieve, washing to obtain a polyester fiber aggregate, and then filtering the remaining portion by a filtration membrane in vacuum so as to obtain cotton fiber fragments after washing. Embodiments of the present disclosure may provide advantages for the separation, recycling and reuse of waste polyester-cotton textiles. For example, the catalyst used during processing is derived from nature and is biodegradable.

Abstract: The present disclosure provides a solution preparation for aerosol inhalation of carbocisteine, and a preparation method therefor. The solution preparation for aerosol inhalation of carbocisteine of the present disclosure comprises carbocisteine, a salt thereof and/or a hydrate thereof, a metal complexing agent, a pH adjusting agent, and water for injection. The solution preparation for aerosol inhalation of carbocisteine of the present disclosure has the characteristics of high efficiency, low toxicity, good stability and high safety, and particularly, greatly reduces the hepatotoxicity and the renal toxicity to patients using the drug.

Abstract: The human body sensing device includes a contact sensing unit that includes a sensing electrode and a signal electrode, an activation module that senses a contact with a body through the sensing electrode when the sensing electrode and the signal electrode contact the body and outputs a wake-up signal in response to the sensing of the contact, and a human body communication unit that provides a ground voltage to the signal electrode and outputs a data signal to the signal electrode when the wake-up signal from the activation module is received.

Abstract: The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IX? reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.

Abstract: The present disclosure relates to the use of silica-forming peptides (SFPs) Volp1 and Salp1 for protein fusion tags for protein purification, silica formation and self-encapsulation, and controlled release of biomolecules. After preparing a fusion protein containing the Volp1 or Salp1 peptide at the C-terminal of the protein, the adsorption conditions for silica (SiO2) surface were optimized. As a result, a high-purity fusion protein could be purified without an additional tag for purification. The fusion protein containing the silica-forming peptide was self-encapsulated and stably immobilized in the silica matrix through reaction with a silica precursor. The Volp1 and Salp1 peptides showed stronger adsorption ability for silica than the previously known R5 peptide. Using these characteristics, a silica complex wherein two proteins are encapsulated was prepared by mixing the R5 fusion protein with the Volp1 or Salp1 fusion protein.

Abstract: This document relates to methods and materials for assessing and/or treating mammals (e.g., humans) having one or more polyps (e.g., one or more colon polyps). For example, this document provides methods and materials for determining if a polyp (e.g., a polyp within a mammal having one or more polyps) is likely to recur and/or likely to progress to a cancer. This document also provides methods and materials for treating a mammal having one or more polyps.

Abstract: The present invention relates to a covering element for a portable object made of a first material, the first material being a ceramic material having a first color, characterized in that the surface of said covering element is at least partially treated so as to exhibit at least one conversion having a different color from the first color.